Kumar Amit, Cannon Christopher P
University of Massachusetts Medical School, Worcester, MA, USA.
Heart Fail Clin. 2008 Apr;4(2):129-39. doi: 10.1016/j.hfc.2008.01.010.
Patients who have acute coronary syndrome complicated by heart failure have increased short- and long-term morbidity and mortality. Besides the proven action in reducing cardiovascular events and mortality, statins also reduce the risk of developing heart failure after acute coronary syndrome. The pathways responsible for this benefit are likely a result of the "pleiotropic" actions of statins. The ongoing trials of statins in patients who have heart failure will help to further characterize this benefit.
患有急性冠状动脉综合征并伴有心力衰竭的患者,其短期和长期发病率及死亡率均有所增加。除了已证实的降低心血管事件和死亡率的作用外,他汀类药物还可降低急性冠状动脉综合征后发生心力衰竭的风险。这种益处背后的机制可能是他汀类药物“多效性”作用的结果。正在进行的针对心力衰竭患者的他汀类药物试验将有助于进一步明确这种益处。